Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -1.18% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 29.64%. Over the past 30 days, the price of TEVA has leaped by -1.94%. And in the last five days, it has fallen by -0.64%.
Teva- Pharmaceutical Industries Ltd. ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $22.80 on 12/27/24, while the lowest price for the same duration was marked at $11.48 on 01/30/24.
52-week price history of TEVA Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is -4.47% away from its 52-week high, while its distance from the 52-week low is 89.72%. The stock’s price range during this time has been between $11.48 and $22.80. The trading volume for the Healthcare sector company’s shares reached about 10.78 million for the day, which was higher than the average daily volume of 9.48 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 18.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 24.71B and boasts a workforce of 37226 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 18.67, with a change in price of +2.91. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 8,250,206 in trading volume during the last 100 days, posting a change of +15.42%.
TEVA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 3.18. Similarly, the long-term debt-to-equity ratio is also 2.75.
TEVA Stock Stochastic Average
Today, Teva- Pharmaceutical Industries Ltd. ADR’s raw stochastic average for the past 50 days stands at 84.66%, indicating a rise from the raw stochastic average of the last 20 days, which was 61.58%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 60.45% and 62.96% respectively.
